Exactech, Inc. (EXAC) Q3 Revenue Up 8% to $51.3M, Net Income Up 95% to $2.6M, EPS $0.19; YTD Revenue Up 8% to $165.1M, Net Income $8.9M, EPS $0.67
10/31/2012 8:33:06 AM
GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $51.3 million for the third quarter of 2012, an 8% increase over $47.3 million in the third quarter of 2011. Net income increased 95% to $2.6 million, or $0.19 per diluted share, compared to $1.3 million, or $0.10 per diluted share, in the same quarter a year ago.
comments powered by